Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The global Active Pharmaceutical Ingredients/APImarket was valued at USD 157.87billion in 2016 and is projected to reach USD 271.97billionby 2025, growing at a CAGR of 6.23% from 2017 to 2025.
An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. With increased investments and focus on API and its applications in R&D, the market is expected to grow at a high rate during the forecast period.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing Prevalence of chronic disorders
1.2 Increase cases of cancer
1.3 Technological advancements in API
1.4 Increasing geriatric population
1.5 Increasing scope of generics
1.6 Expansion of applications of biopharmaceuticals
2. Market Restraints
2.1 Unfavorable Drug pricing poilicies
2.2 Stringent regulations
Market Segmentation:
1. By Therapeutic Application:
1.1 Oncology
1.2 Cardiovascular Disease
1.3 Diabetes
1.4 Central Nervous System and Neurological Disorders
1.5 Endocrinology
1.6 Other Therapeutic Applications
2. By Type of Drug:
2.1 Prescription Drugs
2.2 Over-The-Counter Drugs
2.3 Active Pharmaceutical Ingredients Market, By Potency
2.3.1 Low to Moderate Potency Active Pharmaceutical Ingredients
2.3.2 Potent to Highly Potent Active Pharmaceutical Ingredients
3. By Type of Synthesis:
3.1 Synthetic Active Pharmaceutical Ingredients
3.1.1 Innovative Synthetic APIs
3.1.2 Generic Synthetic APIs
3.2 Biotech Active Pharmaceutical Ingredients
3.2.1 By Type
3.2.1.1 Innovative Biotech APIs
3.2.1.2 Biosimilars
3.2.2 By Product
3.2.2.1 Monoclonal Antibodies
3.2.2.2 Vaccines
3.2.2.3 Hormones and Growth Factors
3.2.2.4 Cytokines
3.2.2.5 Fusion Proteins
3.2.2.6 Therapeutic Enzymes
3.2.2.7 Blood Factors
3.2.3 By Expression System
3.2.3.1 Mammalian Expression Systems
3.2.3.2 Microbial Expression Systems
3.2.3.3 Yeast Expression Systems
3.2.3.4 Plant Expression Systems
3.2.3.5 Insect Expression Systems
4. By Type of manufacturer:
4.1 Captive Manufacturers
4.2 Merchant API Manufacturers
5. By Type:
5.1 Innovative Active Pharmaceutical Ingredients
5.2 Generic Active Pharmaceutical Ingredients
6. By Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Pfizer, Inc.
2. Novartis International AG
3. Sanofi
4. BoehringerIngelheim
5. Bristol-Myers Squibb
6. Teva Pharmaceutical Industries Ltd.
7. ELI Lilly and Company
8. Glaxosmithkline PLC
9. Merck & Co., Inc.
10. Abbvie Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Active Pharmaceutical Ingredients/APImarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
Request Sample 
Request Discount 
Inquire Before Buy
